Skip to Content

Press Releases

Press Releases

Tiziana Life Sci PLC - Price Monitoring Extension
Jun 19, 2020
Tiziana Life Sci PLC - Patent Granted for Oral Administration
Jun 19, 2020
Tiziana Granted First-Ever Patent on a Transformational Technology for Oral Delivery of all Anti-CD3 Monoclonal Antibodies for Treatment of Human Diseases
Jun 19, 2020
Tiziana Life Sci PLC - Directorate Change
Jun 18, 2020
Tiziana Life Sci PLC - Final Results
Jun 18, 2020
Tiziana Life Sci PLC - Extension of At the Market Sales Agreement
Jun 12, 2020
Tiziana Life Sciences announces that its Scientific Advisory Board Chairman Dr. Howard Weiner received NIH grant to investigate Nasal Anti-CD3 for the treatment of Alzheimer’s disease
Jun 04, 2020
Tiziana Life Sci PLC - Anti-CD3 for Alzheimer Disease
Jun 04, 2020
Tiziana Life Sci PLC - Issue of Equity and Total Voting Rights
Jun 02, 2020
Tiziana Life Sci PLC - Change of Adviser
Jun 01, 2020
Displaying 11 - 20 of 225